207 related articles for article (PubMed ID: 36811232)
1. RNA epigenetic modifications in ovarian cancer: The changes, chances, and challenges.
Ye L; Yao X; Xu B; Chen W; Lou H; Tong X; Fang S; Zou R; Hu Y; Wang Z; Xiang D; Lin Q; Feng S; Xue X; Guo G
Wiley Interdiscip Rev RNA; 2023; 14(5):e1784. PubMed ID: 36811232
[TBL] [Abstract][Full Text] [Related]
2. N6-Methyladenosine-Related RNA Signature Predicting the Prognosis of Ovarian Cancer.
Jiao J; Jiang L; Luo Y
Recent Pat Anticancer Drug Discov; 2021; 16(3):407-416. PubMed ID: 34137363
[TBL] [Abstract][Full Text] [Related]
3. RNA Modifications and Epigenetics in Modulation of Lung Cancer and Pulmonary Diseases.
Teng PC; Liang Y; Yarmishyn AA; Hsiao YJ; Lin TY; Lin TW; Teng YC; Yang YP; Wang ML; Chien CS; Luo YH; Chen YM; Hsu PK; Chiou SH; Chien Y
Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638933
[TBL] [Abstract][Full Text] [Related]
4. The Emerging Roles and Therapeutic Implications of Epigenetic Modifications in Ovarian Cancer.
Wang Y; Huang Z; Li B; Liu L; Huang C
Front Endocrinol (Lausanne); 2022; 13():863541. PubMed ID: 35620395
[TBL] [Abstract][Full Text] [Related]
5. The potential regulatory role of RNA methylation in ovarian cancer.
Zhao S; Zhang M; Zhu X; Xing J; Zhou J; Yin X
RNA Biol; 2023 Jan; 20(1):207-218. PubMed ID: 37194218
[TBL] [Abstract][Full Text] [Related]
6. Ovarian cancer subtypes based on the regulatory genes of RNA modifications: Novel prediction model of prognosis.
Zheng P; Li N; Zhan X
Front Endocrinol (Lausanne); 2022; 13():972341. PubMed ID: 36545327
[TBL] [Abstract][Full Text] [Related]
7. Novel insight into the regulatory roles of diverse RNA modifications: Re-defining the bridge between transcription and translation.
Shi H; Chai P; Jia R; Fan X
Mol Cancer; 2020 Apr; 19(1):78. PubMed ID: 32303268
[TBL] [Abstract][Full Text] [Related]
8. Interplays of different types of epitranscriptomic mRNA modifications.
Rengaraj P; Obrdlík A; Vukić D; Varadarajan NM; Keegan LP; Vaňáčová Š; O'Connell MA
RNA Biol; 2021 Oct; 18(sup1):19-30. PubMed ID: 34424827
[TBL] [Abstract][Full Text] [Related]
9. Gene Signatures and Prognostic Values of m6A RNA Methylation Regulators in Ovarian Cancer.
Han X; Liu J; Cheng G; Cui S
Cancer Control; 2020; 27(1):1073274820960460. PubMed ID: 32951457
[TBL] [Abstract][Full Text] [Related]
10. [Progress in epigenetic modification of mRNA and the function of m6A modification].
Gan H; Hong L; Yang F; Liu D; Jin L; Zheng Q
Sheng Wu Gong Cheng Xue Bao; 2019 May; 35(5):775-783. PubMed ID: 31222996
[TBL] [Abstract][Full Text] [Related]
11. The dynamic RNA modification 5-methylcytosine and its emerging role as an epitranscriptomic mark.
Trixl L; Lusser A
Wiley Interdiscip Rev RNA; 2019 Jan; 10(1):e1510. PubMed ID: 30311405
[TBL] [Abstract][Full Text] [Related]
12. A dynamic reversible RNA N
Bi Z; Liu Y; Zhao Y; Yao Y; Wu R; Liu Q; Wang Y; Wang X
J Cell Physiol; 2019 Jun; 234(6):7948-7956. PubMed ID: 30644095
[TBL] [Abstract][Full Text] [Related]
13. RNA epigenetics--chemical messages for posttranscriptional gene regulation.
Roundtree IA; He C
Curr Opin Chem Biol; 2016 Feb; 30():46-51. PubMed ID: 26625014
[TBL] [Abstract][Full Text] [Related]
14. RNA modifications as a common denominator between tRNA and mRNA.
Levi O; Arava YS
Curr Genet; 2021 Aug; 67(4):545-551. PubMed ID: 33683402
[TBL] [Abstract][Full Text] [Related]
15. The lncRNA epigenetics: The significance of m6A and m5C lncRNA modifications in cancer.
Cusenza VY; Tameni A; Neri A; Frazzi R
Front Oncol; 2023; 13():1063636. PubMed ID: 36969033
[TBL] [Abstract][Full Text] [Related]
16. RNA m
Wang Z; Zhou J; Zhang H; Ge L; Li J; Wang H
Mol Oncol; 2023 Feb; 17(2):195-229. PubMed ID: 36260366
[TBL] [Abstract][Full Text] [Related]
17. Epigenomics in stress tolerance of plants under the climate change.
Kumar M; Rani K
Mol Biol Rep; 2023 Jul; 50(7):6201-6216. PubMed ID: 37294468
[TBL] [Abstract][Full Text] [Related]
18. Identification and validation of a seven m6A-related lncRNAs signature predicting prognosis of ovarian cancer.
Song Y; Qu H
BMC Cancer; 2022 Jun; 22(1):633. PubMed ID: 35676619
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic regulation of proprotein convertase PACE4 gene expression in human ovarian cancer cells.
Fu Y; Campbell EJ; Shepherd TG; Nachtigal MW
Mol Cancer Res; 2003 Jun; 1(8):569-76. PubMed ID: 12805404
[TBL] [Abstract][Full Text] [Related]
20. Comprehensive of N1-Methyladenosine Modifications Patterns and Immunological Characteristics in Ovarian Cancer.
Liu J; Chen C; Wang Y; Qian C; Wei J; Xing Y; Bai J
Front Immunol; 2021; 12():746647. PubMed ID: 34777359
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
